GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuantaMatrix Inc (XKRX:317690) » Definitions » LT-Debt-to-Total-Asset

QuantaMatrix (XKRX:317690) LT-Debt-to-Total-Asset : 0.59 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is QuantaMatrix LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. QuantaMatrix's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.59.

QuantaMatrix's long-term debt to total assets ratio increased from Dec. 2023 (0.02) to Dec. 2024 (0.59). It may suggest that QuantaMatrix is progressively becoming more dependent on debt to grow their business.


QuantaMatrix LT-Debt-to-Total-Asset Historical Data

The historical data trend for QuantaMatrix's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuantaMatrix LT-Debt-to-Total-Asset Chart

QuantaMatrix Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.02 0.02 0.02 0.02 0.59

QuantaMatrix Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.02 0.02 0.59

QuantaMatrix LT-Debt-to-Total-Asset Calculation

QuantaMatrix's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )/Total Assets (A: Dec. 2024 )
=15929.907/26826.503
=0.59

QuantaMatrix's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=15929.907/26826.503
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QuantaMatrix  (XKRX:317690) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


QuantaMatrix LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of QuantaMatrix's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


QuantaMatrix Business Description

Traded in Other Exchanges
N/A
Address
131, Gasan digital 1-ro, Geumcheon-gu, 16th floor, Bidong (Gasan-dong, BYC High City), Seoul, KOR, 08506
QuantaMatrix Inc is engaged in research and development, production, and sales of in vitro diagnostic (IVD) medical devices that utilize substances collected from the human body, such as blood, feces, body fluids, and saliva, for the purpose of disease prevention and diagnosis, prognosis prediction, and assessment of health status and treatment effectiveness, targeting domestic and foreign general hospitals and testing contract institutions.

QuantaMatrix Headlines

No Headlines